The keratocystic odontogenic tumour is a bone tumour which is relatively uncommon and benign, however it is very aggressive and has a high recurrence rate after treatment. Some reports have stated 6 out of 10 of these tumours will recur after treatment. Treatment to prevent recurrence can lead to the removal of large amounts of bone surrounding the lesion and this carries major risks (nerve damage, loss of facial form and function). Currently uncertainty exists regarding the best treatment option, this review aimed to help to inform on the strength and direction of available evidence in this respect. This review revealed that there is no high quality evidence for the effectiveness of available treatments and so there is a need for further research to help clinicians and patients to make informed choices about treatment options.
Interventions for the treatment of keratocystic odontogenic tumours (KCOT, odontogenic keratocysts (OKC))
Published Online:
September 8, 2010
Health topics:
More like this
- Interventions for central giant cell granuloma of the jaws
- Interventions for basal cell carcinoma of the skin
- Treatments for non-metastatic squamous cell carcinoma of the skin
- Interventions for preventing of non-melanoma skin cancers in high-risk groups
- Fluorides for the prevention of white spots on teeth during fixed brace treatment
